BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
BioInvent International EPS Diluted (Quarterly): -0.1426 for Sept. 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.1426 |
| June 30, 2024 | -0.1959 |
| March 31, 2024 | -0.1138 |
| December 31, 2023 | -0.1384 |
| September 30, 2023 | -0.1001 |
| June 30, 2023 | -0.1275 |
| March 31, 2023 | -0.1075 |
| December 31, 2022 | -0.1126 |
| September 30, 2022 | -0.0939 |
| June 30, 2022 | 0.2923 |
| March 31, 2022 | -0.1245 |
| December 31, 2021 | -0.1529 |
| September 30, 2021 | -0.1239 |
| June 30, 2021 | -0.1166 |
| March 31, 2021 | -0.2317 |
| December 31, 2020 | 0.0842 |
| September 30, 2020 | -0.113 |
| June 30, 2020 | -0.2069 |
| March 31, 2020 | -0.1695 |
| December 31, 2019 | -0.2089 |
| September 30, 2019 | -0.1826 |
| June 30, 2019 | -0.182 |
| March 31, 2019 | -0.2145 |
| December 31, 2018 | -0.2443 |
| September 30, 2018 | -0.1648 |
| Date | Value |
|---|---|
| June 30, 2018 | -0.3405 |
| March 31, 2018 | -0.2425 |
| December 31, 2017 | -0.3238 |
| September 30, 2017 | -0.211 |
| June 30, 2017 | -0.2226 |
| March 31, 2017 | -0.1921 |
| December 31, 2016 | -0.0542 |
| September 30, 2016 | -0.2875 |
| June 30, 2016 | -0.2984 |
| March 31, 2016 | 0.0058 |
| December 31, 2015 | -0.3746 |
| September 30, 2015 | -0.404 |
| June 30, 2015 | -0.5527 |
| March 31, 2015 | -0.5597 |
| December 31, 2014 | -0.8242 |
| September 30, 2014 | -0.294 |
| June 30, 2014 | 0.1375 |
| March 31, 2014 | -0.6978 |
| December 31, 2013 | 0.8812 |
| September 30, 2013 | -0.5951 |
| June 30, 2013 | -0.4064 |
| March 31, 2013 | -0.605 |
| December 31, 2012 | -0.8413 |
| September 30, 2012 | -1.430 |
| June 30, 2012 | -3.504 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.2317
Minimum
Mar 2021
0.2923
Maximum
Jun 2022
-0.1102
Average
-0.1242
Median
EPS Diluted (Quarterly) Benchmarks
| Abliva AB | -0.0019 |
| Oncopeptides AB | -0.0417 |
| Hansa Biopharma AB | -0.1475 |
| BioArctic AB | -0.0722 |
| Camurus AB | 0.2081 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.370M |
| Revenue (Quarterly) | 1.23M |
| Total Expenses (Quarterly) | 11.55M |
| Enterprise Value | 215.05M |
| Profit Margin (Quarterly) | -761.8% |
| Earnings Yield | -12.57% |
| Normalized Earnings Yield | -13.37 |